+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
Manidipine (CAS 89226-50-6) Global Market Research Report 2024 - Product Thumbnail Image

Manidipine (CAS 89226-50-6) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Meglutol (CAS 503-49-1) Global Market Research Report 2024 - Product Thumbnail Image

Meglutol (CAS 503-49-1) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Lacidipine (CAS 103890-78-4) Global Market Research Report 2024 - Product Thumbnail Image

Lacidipine (CAS 103890-78-4) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Metaraminol (CAS 54-49-9) Global Market Research Report 2024 - Product Thumbnail Image

Metaraminol (CAS 54-49-9) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Losartan (CAS 114798-26-4) Global Market Research Report 2024 - Product Thumbnail Image

Losartan (CAS 114798-26-4) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Lisinopril (CAS 76547-98-3) Global Market Research Report 2024 - Product Thumbnail Image

Lisinopril (CAS 76547-98-3) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Lidoflazine (CAS 3416-26-0) Global Market Research Report 2024 - Product Thumbnail Image

Lidoflazine (CAS 3416-26-0) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
From
Isradipine (CAS 75695-93-1) Global Market Research Report 2024 - Product Thumbnail Image

Isradipine (CAS 75695-93-1) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Isoxsuprine (CAS 395-28-8) Global Market Research Report 2024 - Product Thumbnail Image

Isoxsuprine (CAS 395-28-8) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Imidapril (CAS 89371-37-9) Global Market Research Report 2024 - Product Thumbnail Image

Imidapril (CAS 89371-37-9) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Guanabenz (CAS 5051-62-7) Global Market Research Report 2024 - Product Thumbnail Image

Guanabenz (CAS 5051-62-7) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Fendiline (CAS 13042-18-7) Global Market Research Report 2024 - Product Thumbnail Image

Fendiline (CAS 13042-18-7) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Flosequinan (CAS 76568-02-0) Global Market Research Report 2024 - Product Thumbnail Image

Flosequinan (CAS 76568-02-0) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
From
From
Hexobendine (CAS 54-03-5) Global Market Research Report 2024 - Product Thumbnail Image

Hexobendine (CAS 54-03-5) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Arbutamine (CAS 128470-16-6) Global Market Research Report 2024 - Product Thumbnail Image

Arbutamine (CAS 128470-16-6) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Aranidipine (CAS 86780-90-7) Global Market Research Report 2024 - Product Thumbnail Image

Aranidipine (CAS 86780-90-7) Global Market Research Report 2024

  • Report
  • February 2025
  • 50 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more